Streck launches Liquid Biopsy Accelerator Grant to advance non-invasive cancer detection research

Streck is thrilled to announce the launch of its inaugural Liquid Biopsy Accelerator Grant. This initiative aims to support innovative research in blood-based early cancer detection and other non-invasive diagnostic strategies.

The grant will award five applicants with $2,500 in product credit for use with Streck stabilization products. One grand prize winner will receive an additional $7,500 product credit and a sponsored trip to the American Association for Cancer Research (AACR) Annual Meeting in 2026.

“The future of diagnostics depends on researchers who can turn emerging technologies into practical solutions that improve lives,” said Kevin Billings, director of Business Segment – Stabilization at Streck. “Through this grant, we hope to accelerate promising liquid biopsy work and provide scientists with the resources they need to make meaningful progress.”

The grant is open to academic laboratories and early-stage companies based in the United States with research focused on translational or clinical applications of liquid biopsy. Applicants must use Streck stabilization products as part of their proposed work and will be evaluated based on scientific merit, innovation and alignment with the grant mission.

Proposals are due by August 31, 2025, at 11:59 p.m. CST. Selected applicants will be notified no later than November 12, 2025.

For full eligibility requirements and to apply, click here.